Current Oncology, Free Full-Text
4.9 (330) In stock
Triple-negative breast cancer (TNBC) has a worse prognosis and remains the most challenging breast cancer subtype to treat. This is largely related to the heterogeneity of this disease and the lack of reliable oncological targets. In this review, we discuss the current standard-of-care treatment options for metastatic TNBC, including recent advances with the use of immunotherapy, PARP inhibitors and antibody-drug conjugates. This review also explores new agents and novel combinations arising in the field for the treatment of advanced TNBC.
Home page Cardio-Oncology
Creative Options, ADT Program, Creative Options
Current Oncology, Free Full-Text
📆 Save the date - West Cancer Center & Research Institute
Current Oncology, Free Full-Text, Skin Tone Construction Paper
Current Oncology, Free Full-Text
Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer
Journal of Clinical Oncology
Current Oncology, Free Full-Text
Randomized Trial of Cytoreductive Surgery for Relapsed Ovarian Cancer
Cancer Support Groups, Counseling, Education & Financial Assistance
Paigey🥢 on X: Hopefully this is a conversation starter… What are
About TNBC – I Can. We Will.
This woman with triple Q breast implants has spent over $1 million in plastic surgery
- Bezier Curve in Computer Graphics.docx
- Baby bees are like baby gnats: full size - Honey Bee Suite
- Cargo Pant For Girl And Women Cotton Blend Lycra Lower
- Avia Leggings Women's M (8-10) Activewear Teal Tundra Stretch Gym
- merino Yarn in Ottawa, Canada – Wabi Sabi
- PUMA womens PERFORMANCE FULL TIGHT,Black,X-Small price in Saudi Arabia, Saudi Arabia